Follow us

MaxCyte (MXCT)

MaxCyte (MXCT) presentation at ShareSoc July 2018

16 July 2018

Driving the next generation of cell-based medicines
By Doug Doerfler – Founder, President & CEO

Introduction – 00:23
Background and what MaxCyte does – 02:41
Business model – 04:11
CARMA platform, CAR therapy in oncology – 09:07
Cell therapy programmes – business model – 16:12
Revenue potential across multiple applications – 19:15
Expected news flow – 21:36
Summary & outlook – 22:18
2017 financial highlights – 22:50
Q&A – 23:45


Presentation slides can be viewed here.

Listen on the go


PIWORLD provides investors with the latest news and insight about listed companies and their management through either live or recorded investor presentations, management interviews, Capital Market Days and corporate overviews, together with interviews with leading fund managers or esteemed private investors in the small cap world.

Our Services

PIWORLD delivers high quality audio and video content to present anything from full-year & interim results to Capital Markets Days and corporate overviews. We bridge the gap between listed companies and the private investor community, who drive the share price and provide liquidity, providing a time and cost effective medium to reach this diverse and important audience.